Industry Focus Transcripts

Square is down more than 20% since issuing its second-quarter earnings. Here’s what investors should know.

Let’s take a step back and put it into perspective.

Here’s a fintech company and a small bank on our radar.

The deal creates a massive enterprise that will boast 140,000 employees, $16 billion of annual revenue, and a global scale that overshadows its closest competitors by a wide margin.

On business, future trends, and the contrasting U.S. and China business environments.

Three stocks to have on your radar in the healthcare space.

Stitch Fix stock went up by nearly 70% in the past week alone. Can it maintain the momentum?

The subscription service keeps customers from having to go to stores.

Its focused approach to payments is what differentiates it from other players in the space.

Selling your home with the click of a button has its perks, but myriad challenges still exist for Zillow Offers.

We said what? Let’s face it: Sometimes our predictions miss the mark, and with Rite Aid and Opko Health, they missed the mark by a lot. Here’s what we said, why we said it, and what we learned from our mistakes.

These been-there-done-that leaders are at the helm of four different emerging companies that investors should be paying attention to.

The company sells pop-culture collectibles, but much of its business comes from one model.

TripAdvisor and Booking Holdings present two different and compelling sides of a rapidly-growing industry -- here’s what investors need to know.

Before Amazon, Rakuten was the No. 1 e-commerce player in Japan. We bring you an in-depth analysis of the company.

Batteries: packed with power from renewable energy.

A business that promises to disrupt the medical imaging industry.

Checking back in on Nano-X -- the Tesla of medical imaging.

The Fools discuss one of today's most controversial health companies.

ADT has been on the decline since its IPO -- is this a buying opportunity, or should long-term investors wait this one out?